Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of semaphorin-4D binding molecules for the treatment of Rett syndrome

Use of semaphorin-4D binding molecules for the treatment of Rett syndrome

US Patent 11597765 · Granted Mar 7, 2023

Estimated economic value: $432,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy2025
Use of semaphorin-4D antibodies in combination with an immune modulating therapy2024
Use of semaphorin-4D antibodies in combination with an immune modulating therapy2024
Human anti-semaphorin 4D antibody2024
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy2023
Treatment of cancer with a semaphorin-4D antibody in combination with an epigene2023
Treatment of cancer with a semaphorin-4D antibody in combination with an epigene2023
Use of semaphorin-4D binding molecules for modulation of blood brain barrier per2022
Human anti-semaphorin 4D antibody2022
Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to i2021
Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to i2021
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders2020